A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...

Today in History for Jan. 29: ...

A slightly disappointing revenue outlook from Pfizer (PFE) was enough for its COVID-19 vaccine rivals Moderna (MRNA) and Novavax (NVAX) to trade lower on Tuesday, just as a major safety scare related ...

Stanford researchers identify a two-step immune reaction underlying rare myocarditis cases after mRNA COVID vaccination, primarily in adolescent males and young men. Cases typically resolve quickly ...

“The impact that shifting from universal to shared clinical decision-making (otherwise known as individual-based decision-making) will have on COVID-19 vaccination coverage or effectiveness in ...

The Food and Drug Administration (FDA) is investigating whether the COVID-19 vaccines were associated with any deaths across all age ranges. “FDA is doing a thorough investigation, across multiple age ...

The dollar has surged, pushed higher by investors searching for protection against disappointing stocks and bonds. But it is weighing on emerging-markets currencies and spurring inflation fears. South ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...

Vials of the Pfizer-BioNTech COVID-19 vaccine are shown in 2023. It was formulated using mRNA technology. Lee S. Weissman USA TODAY NETWORK COLUMBIA, S.C. Before receiving another dose of a COVID-19 ...